| Date | Thursday, May 19, 2022 |
| Time | 10:00 (GMT+7) |
| Venue | Auditorium Room 4th floor
Kalbe Business Innovation Center
Pulogadung St No.23, Lot. No. II G.5. KIP,
Jatinegara, Kec. Cakung, East Jakarta |
| Agenda | AGMS - Approval and ratification of the company's Annual Report of the financial year 2021, including the company's Activity Report, the Board of Commissioners Oversight Report and the company's Financial Report of the financial year 2021, and to release and discharge of all responsibilities (volledig acquit et de charge) to all Board members for the management and supervision carried out in the financial year 2021.
- Approval on the use of the company profit of the financial year 2021.
- Change of the company management composition.
- Determination of salary and/or honorarium for all Board members; delegation of authority to Board of Commissioners to determine salaries and/or honorarium for Board of Directors, taking into account the recommendations of the company's Nomination and Remuneration Committee;
- Election of a Registered Public Accountant Firm to audit the company Financial Report of the financial year 2022.
|
DH/W
KLBF - PT. Kalbe Farma Tbk
Rp 1.245
-75 (-5,68%)
